GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93021C00041LUNA LABS USA LLC

Overview

Award facts

Net obligations
$1.50M
$1,499,998of $1.50M potential value
Outlays (paid to date)
$1.50M
$1.50M paid of $1.50M obligated$1,499,998
Period of performance
Sep 3, 2021 to May 31, 2025
Ended
Modifications
7
Latest action Mar 20, 2025
Contract type
Definitive contract
PIID 75N93021C00041

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

INNOVATIVE PEDIATRIC ORAL FORMULATIONS FOR SECOND LINE TUBERCULOSIS DRUGS

Dates and value

Award date
Signed on Sep 3, 2021
Potential end of performance
May 30, 2025
Current value
$1,499,998Base and exercised options
Potential value (if all options are exercised)
$1,499,998

Obligations by fiscal year of action

  • FY2021: $1,499,998

Total across 1 fiscal year: $1,499,998

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 20, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationCHARLOTTESVILLE, VA
UEIM6JVSYRQRYM9
CAGE code8JML8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyLUNA LABS USA LLC

Business types and certifications

For-profit organizationLimited liability companyCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Roanoke, Roanoke City, Virginia 24011-1909
Congressional district (place of performance)
VA-06As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
7

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Services pursuant to FAR 12.102(G)C
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 3, 2021Base obligation at award: $1,499,998
Latest action
Mar 20, 2025 — Other administrative actionModification P00007; administrative: no change in scope or value
Latest substantive action
Jul 25, 2024 — Supplemental agreement (within scope)Modification P00005
Actions by type
  • Base award1
  • Other administrative action5
  • Supplemental agreement (within scope)1
  • Novation (contract transferred)1
8 actions recorded, Sep 3, 2021 to Mar 20, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
8

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2021/2021-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression